| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $209.7M | — | -0.3% |
| Cost of Revenue | $64.7M | — | +8.9% |
| Gross Profit | $144.9M | — | -3.9% |
| R&D Expense | $48.4M | — | +1.0% |
| SG&A Expense | $18.2M | — | -22.8% |
| Operating Income | -$558K | — | -452.5% |
| Pre-tax Income | $1.8M | — | -61.9% |
| Income Tax | $700K | — | -74.1% |
| Net Income | $1.1M | — | -46.3% |
| EPS (Basic) | $0.02 | — | -33.3% |
| EPS (Diluted) | $0.02 | — | -33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $343.3M | +39.2% | +17.8% |
| Short-term Investments | $327.0M | +43.4% | +61.9% |
| Current Assets | $900.3M | +22.1% | +22.9% |
| Total Assets | $1.72B | -0.4% | +4.5% |
| Current Liabilities | $1.15B | +100.7% | +96.0% |
| Total Liabilities | $1.54B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $39.8M | — | +33.8% |
| Capital Expenditures | $2.1M | — | +52.9% |
| Investing Cash Flow | $55.3M | — | +169.8% |
| Financing Cash Flow | $2.6M | — | -44.3% |
| Free Cash Flow | $37.7M | — | +32.9% |
| -3.0% |
| Stockholders' Equity | $174.8M | +13.0% | +231.5% |